CD4 and myeloid sarcoma: In addition, using classical in vitro suppressor assays, we observed that CD4+ and CD8+ T cells from therapy-naive MS patients were resistant to Treg-mediated suppression of independent third healthy individuals when compared to T cells from HD (Figure 1).